LEGN financials
Legend Biotech (LEGN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
LEGN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $1.03B | $620.80M | -$136.50M | -$296.80M | -1.60 |
| 2024 | $627.24M | $392.66M | -$303.24M | -$177.03M | -0.97 |
| 2023 | $285.14M | $140.93M | -$439.49M | -$518.25M | -2.94 |
| 2022 | $117.00M | $51.64M | -$455.62M | -$446.35M | -2.81 |
| 2021 | $68.83M | $68.83M | -$392.29M | -$403.58M | -2.74 |
| 2020 | $75.00M | $75.00M | $0.00 | -$266.37M | -2.57 |
- LEGN revenue was $1.03B in fiscal 2025, net income -$296.80M.
Updated 2026-11-03 11:33 UTC